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The COVID-19 pandemic has had a profound global impact.  Its rapid transmissibility has transformed 
healthcare delivery and forced countries to adopt strict measures to contain its spread.  The vast majority 
of U.S. cardiac surgical programs have deferred all but truly emergent/urgent operative procedures in an 
effort to reduce the burden on the healthcare system and to mobilize resources to combat the pandemic 
surge.  While the number of COVID-19 cases continues to increase worldwide, the incidence of new 
cases has begun to decline in many North American cities.  This “flattening of the curve” has prompted 
interest in re-opening the economy, relaxing public health restrictions, and resuming non-urgent healt 
care delivery.   
 
The following document provides a template whereby adult cardiac surgical programs may begin to ramp 
up the care delivery in a deliberate and graded fashion as the COVID-19 pandemic burden begins to ease.  
“Resuscitating” the timely delivery of care is guided by three principles (Figure 1): 
1. Collaborate to permit increased case volumes, balancing the clinica  needs of patients awaiting 
surgery against the local resources available within each healthcare system. 
2. Prioritize patients awaiting elective surgery while proactively engaging all stakeholders, 
focusing on those with high-risk anatomy, changing/symptomatic clinical status, and, once these 
variables have been addressed, prioritizing by waittimes. 
3. Re-evaluate local conditions continuously, to assess for any increase in admissions due to a 
recrudescence of cases, to assure adequate resources to care for patients, and to monitor in-
hospital infectious transmissions to both patients a d health care workers. 
Keywords: COVID-19, ramp up, infection control, healthcare worker safety, testing, quality 
improvement, patient safety 
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The Society of Thoracic Surgeons COVID-19 Task Force and the Workforce for Adult Cardiac and 
Vascular Surgery recently published guidance documents r lated to the practice of cardiac surgery during 
the acceleration phase of the COVID-19 pandemic.1,2  These documents were aimed at providing cardiac 
surgeons with guidance regarding patient triage, leadership, and infection risk reduction during the 
pandemic surge. In many locations, however, the incidence of new cases of COVID-19 are plateauing or 
declining after demonstrated flattening of the epidmiologic curve.  Consideration must now be made 
how best to safely modify public health restrictions and resume non-urgent/emergent healthcare delivery, 
specifically elective cardiac surgery. 
 
During the early phases of the pandemic, significant efforts were made to prioritize and defer non-urgent 
cases to preserve mechanical ventilators and other critical care resources, personal protective equipment 
(PPE), blood products, hospital beds, and maintain sufficient healthcare personnel in preparation for the 
pandemic surge.  In addition, the CDC recommended3 laying elective inpatient and outpatient surgeries 
and procedures. This recommendation was intended to pro ect healthcare workers and uninfected, 
vulnerable patients (i.e. older with cardiovascular disease) by limiting their exposure to those with known 
COVID-19 and asymptomatic, undiagnosed carriers of the virus.  However, there is growing concern 
about the increased risk of further delaying cardiac surgical procedures with established survival benefits.  
Programs need to start planning for the resumption of care for patients awaiting postponed elective 
surgery.  
 
However, any decision to “ramp up” surgical case volume will require thoughtful and appropriate caution, 
with frequent re-evaluation as we navigate through the uncertainties of this global pandemic.  There will 
be a need to make collaborative decisions with precise local and regional situational awareness of disease 
burden, carefully balancing the risks and benefits o  increasing surgical case volume.  Furthermore, we 
must maintain flexibility to readjust our escalation strategy in response to evolving conditions and rapidly 




populations re-emerge from lockdown, and the potential for increased COVID-19 infections in 
combination with other seasonal respiratory pathogens such as influenza virus. 
 
Based on the expert opinions of cardiac surgical and critical care leaders, these guidance statements 
provide a template whereby cardiac surgical programs may consider safely increasing case volume in a 
deliberate and graded fashion as the COVID-19 local disease burden begins to ease. 
 
1. Working with public health officials, local COVID-19 prevalence in the community must be 
under control.  Communities should either have a low COVID-19 burden that can be physically 
isolated within the hospital or a consistent decrease in COVID-19 incidence creating the resource 
capacity to perform elective surgery.4  If COVID-19 incidence resurges locally, plans should  be 
in place for re-entering the surge mitigation (i.e. surgical triage) phase. 
 
2. Many patients are reluctant to enter hospitals for fea of exposure to COVID-19.5  Patients should  
feel comfortable that they can safely undergo cardiac surgical procedures without significant risk 
of exposure to COVID-19 within the hospital environment. This includes enhanced attention to 
equipment, meals, medication administration, PPE, and interactions with other patients, visitors, 
and hospital personnel.  Hospitals should  adjust policies, protocols and procedures to limit 
patient movement and exposure to potential COVID-19 fomites and personnel.6  All attempts 
should be made to avoid excessive imaging, bloodwork, procedures, and in-hospital transport to 
limit these exposures .7  Recommendations surrounding the need for repeat laboratory testing, 
imaging, and physical examinations should be reassessed.  Video conferencing should be utilized 
for preoperative family meetings and postoperative v sits, where available.  In addition, hospitals’ 
newly formed COVID-19 infection control processes and procedures should be discussed with 
patients at the time of surgical consent.  This necessitates shared decision-making surrounding the 




cardiovascular pathology.  The surgical team should describe the special precautions being 
undertaken and disclose the uncertain risk of nosocomial COVID-19 infection.  Patients should 
be advised of limited hospital visitor policies and the potential for unexpected case cancellations.  
Cardiac surgical patients should be limited to designated COVID-secure units (free from known 
COVID-19 patients), whenever possible. 
 
New signage and messaging should be utilized to educate healthcare workers and patients.  
Offices, clinics, hospital public areas, and waiting rooms should practice physical distancing (e.g., 
six feet spacing of chairs).  Hospital visitation rules need to be carefully considered so as to limit
potential exposures.  Finally, deliberate attempts should  be made to preoperatively assess each 
patient’s potential need for a post-acute care upon discharge, given the high incidence of known 
COVID-19 outbreaks in those facilities.8  Expectations for discharge should be reviewed  
preoperatively as longer hospital stays after heart surgery potentially  place patients at additional  
risk. As such, patients should plan to be safely discharged to their homes as soon as possible 
following uncomplicated surgery.9 
 
3. Healthcare providers should be aware that their safety lso remains a priority. Cardiac surgical 
programs should follow precautions and guidelines that have been put in place by their respective 
institutions, adhering to the recommendations of local, regional and national public health 
authorities to manage and contain COVID-19 transmision.10  The risk of nosocomial infection 
may be significantly reduced by vigilant attention t  frequent hand hygiene, environmental 
cleaning, appropriate use of PPE, the creation of COVID-secure units, social distancing in the 
hospital, and self-isolation of COVID-19 positive halthcare workers.  It is imperative that 
healthcare workers continue to follow institutional po icies about reporting symptoms, 
undergoing testing, and implementing self-quarantine when appropriate.  They must abstain from 




must be in place for healthcare workers who require self-isolation.  This is particularly relevant 
for the small and highly specialized cardiac teams.  In addition, support and treatment services 
should be available for providers who experience mental health concerns or physical and/or 
emotional exhaustion as a result of professional or personal experiences during the pandemic.11,12  
Finally, it is likely that there will be evolution and institutional variation in COVID-19 
nasopharyngeal and serologic screening for asymptomatic healthcare workers.  Healthcare leaders 
must be aware of this dynamic process. 
 
4. Hospitals should develop and implement comprehensiv screening procedures to identify patients 
at increased risk for COVID-19 as cardiac surgical programs begin to ramp up.  These include the 
following:     
a. Standardized clinical screening telephone questionnaires within 48 hours prior to hospital 
admission, focusing on the clinical history of patien s and their cohabitants (including 
viral-like symptoms, anosmia, and ageusia, all of which are frequently associated with 
COVID-19).  
b. Unless recent outpatient testing suggests the patient is infection free, if possible, the 
initial admission should be to a single room within the hospital where rapid same-day 
preoperative additional screening and/or testing may be performed as needed. 
c. Once admitted to the ward, each patient must be clinica ly screened for the signs and 
symptoms of viral illness with COVID-19 testing administered as needed.  
 
5. Nucleic acid amplification testing (NAAT) for COVID-19 (e.g., by polymerase chain reaction 
(PCR)) should be strongly considered for patients i areas of high disease burden, those who have 
recently been exposed to infected individuals, and those who exhibit even mild symptoms.  If 
there has been a recent exposure, a 2-week quarantine is recommended. Finally, when possible, 




currently available that can reliably rule out COVID-19.  Despite this, tests using nasopharyngeal 
(NP) swabs for COVID-19 NAAT, including rapid PCR tes s, are being increasingly performed 
across the country, often with the ability to return results within minutes or hours. In light of this, 
we propose the following guidance regarding COVID-19 test interpretation in the ramp up phase 
based on the best available evidence at this time.  
a. Nasopharyngeal swab NAAT (or its equivalent) for COVID-19 should be considered 
prior to all elective surgery. The timing of sampling should be as close to surgery as 
possible (preferably within 24-48 hours), allowing sufficient time for results to return 
prior to surgery. 
b. When NAAT testing is positive, these results can be very helpful as delaying surgery 
should strongly be considered.  
c. When NAAT testing is negative, results must be interpr ted with caution as false 
negative rates in asymptomatic patients can be as high as 30% - 50%.13,14  Clinical 
sensitivity can be reduced due to poor quality specim n collection15 or specimen 
collection early in the disease process (higher false negative rates have been noted in the 
asymptomatic or pre-clinical period).13 For patients in areas of high COVID-19 disease 
activity who require urgent or emergent surgery, if the NAAT testing and initial symptom 
screen are negative, consider repeat NAAT testing by NP swabs separated > 24 hours 
apart and consulting with local infection control practitioners.  
d. Elective surgical patients with negative NAAT testing in whom the clinical suspicion of 
COVID-19 infection remains high should self-quarantine for 2 week period of 
observation. Prior to surgery, patients should be rescreened for symptoms and exposures 
and retested in conjunction with local infectious di ease consultation. 
e. If postoperatively patients develop a suspicious clinical syndrome concerning for 
COVID-19, additional investigative tools may include repeat nasopharyngeal specimen 




f. Clearly, as improved testing methods become available, they should be utilized, all the 
while recognizing that elective surgery is just that, and a 2-week quarantine with retesting 
may be the safest approach for any patient, regardless of pretest probabilities. 
 
6. Non-urgent patients waiting for prolonged periods prior to surgery are at risk for clinical 
deterioration or adverse events.  Cardiac surgery programs should proactively reassess each 
patient on their waitlist while pursuing a graded increase in elective case volume.  Aspects of this 
management may include, but are not limited to, the following: 
a. All waitlist patients should be contacted via telephone or videoconference for 
reassessment at least every 2 to 4 weeks to assess their clinical status and should be 
instructed to call if their symptoms were to worsen. 
b. Hospitals should have a clear plan in place to formally escalate the care of patients with 
deteriorating symptoms or unstable clinical characteristics, particularly in the face of 
high-risk anatomy. 
c. Peer review among the interdisciplinary heart team is highly encouraged for complex 
patients. 
d. Continued re-evaluation of local pandemic conditions should occur regularly as part of 
the cardiac surgical ramp up strategy. Programs should be prepared to immediately stop 
ramping up or to even de-escalate cardiac surgical volumes should there be a resurgence 
in the number of local COVID-19 cases, admissions, a d deaths. 
 
7. A phased approach is recommended to resuming elective surgery based upon each hospital’s re-
expansion capacity (Figure 1).  We have defined an increase in hospital capacity as the 
percentage of resources previously allocated to the COVID-19 pandemic that have now been 
reallocated to the management of non COVID-19 patients.  Phase 1 reflects up to a 25% increase 




normal institutional activity.  Depending on which p ase of re-expansion your institution is 
currently in, your cardiac surgical program should have a defined approach as to which elective 
cases will be given priority during the ramp up.  The number of elective cases by which each 
program may ramp up depends upon the urgent case deman s at the institution and the overall 
institutional capacity in the context of COVID-19 prevalence and the impact on the healthcare 
workforce. 
 
8. Hospitals should create and operationalize sustainable plans to ensure that they continue to care 
for patients with COVID-19 infections while concurrently addressing all the other healthcare 
needs of their non-infected local populations. Increased surgical volume will consume PPE and 
other resources which should be modelled to ensure capacity. Policies regarding the use of PPE 
during surgery for patients deemed to be non-COVID should be established. Those institutions 
with a high incidence of persistent COVID-19 disease burden will likely need to designate 
separate COVID-care and COVID-secure units for the for seeable future.  We must continue to 
assume that we will have hospitalized symptomatic COVID-19 patients until we have a vaccine 
or sufficient herd immunity.  
 
9. Efforts to escalate cardiac surgical volumes require regular communication between members of 
the cardiac surgical team, intensive care units, hopital administration, and public health officials.  
Ideally, a regional dashboard that provides real-time trending of resource utilization (e.g. hospital 
admissions, ICU admissions, ventilator use, PPE availability) should be created to facilitate 
communication and well-informed forecasting to allow f r thoughtful decision making. 
 
10. Real-time quality assurance teams should be focused on monitoring COVID-19 transmission 
within cardiac surgery units, postoperative complications in the pandemic time period related or 
unrelated to COVID, deficiencies in hospital workflow, or other related quality issues.  Potential 




cardiac intensive care unit, expedited workup or inadequate preoperative testing, “pandemic’ 
level care that does not meet standard of care. 
Summary 
The COVID-19 pandemic has introduced unique challenges for cardiac surgical programs.  Elective cases 
have been cancelled and urgent cases delayed in order t  reallocate resources for patients with COVID-
19.   Waitlists have grown, and those being asked to postpone their surgery have been forced to 
experience necessary but prolonged delays. Patients who were once deemed surgical candidates have 
increasingly been referred for medical management or alternative percutaneous therapies, with potential 
adverse long-term impacts. 
 
The effect of the COVID-19 pandemic on individual hospitals varies widely. It is important for 
institutions to continuously reassess their capabilities and potential limitations, while simultaneously 
surveying for potential subsequent waves of COVID-19.   As new data emerges, these statements may 
change over time given the fluidity and scope of the current pandemic. Geographic differences in 
epidemiology and practice patterns across the country must be acknowledged and do not substitute for 
individualized expertise when operationalizing a deliberate and graded increase in cardiac surgical 
volume as the incidence of COVID-19 begins to ease.   
 
Clearly, economic factors remain highly relevant in U.S. healthcare. Some surgeons are compensated on a 
model that correlates with production of relative value units (RVU). Non-military hospitals are also 
heavily reimbursed based upon procedural volume. Th financial impact to medical centers has also been 
well described and are substantial with hospitals under major financial crises.17 Nevertheless, it is 
imperative that cardiac surgeons advocate in the best interest of their patients and function as good 
citizens for their institutions by supporting the principles stated in the STS Adult Cardiac Triage 
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Figure 1:  Phased implementation approach to cardiac surgery amp-up based on the increase in hospital 
capacity (AS: aortic stenosis; ASD: atrial septal defect; CABG:  coronary artery bypass grafting; CAD: 
coronary artery disease; CHF:  congestive heart failure; ECMO:  extracorporeal membrane oxygenation; 
ELSO:  Extracorporeal Life Support Organization; EF:  ejection fraction; ICU:  intensive care unit; LM: 
left main artery; LAD:  left anterior descending artery; LOS: length of stay; MR: mitral regurgitation; 
PFO: patent foramen ovale; TAVR: trans-catheter aortic valve replacement; VAD: ventricular assist 
device). Reprinted with permission from Hassan A, Arora RC, Adams C, et al. Cardiac Surgery in Canada 
During the COVID-19 Pandemic: A Guidance Statement from the Canadian Society of Cardiac Surgeons. 
Can J Cardiol 2020. 

